Biomarker Discovery and Mechanistic Studies of Prostate Cancer using Targeted Proteomic Approaches

Abstract

The focus of this collaborative work between Drs. Zhu and Kyprianou has been the identification of EMMPRIN, a cell surface protein we identified to be overexpressed in prostate cancer epithelial cells with a high metastatic potential. Our studies in the funding period have identified the involvement of EMMPRIN in cancer development and progression via controlling extracellular matrix remodeling and anchor-independent growth by stimulating MMP production, angiogenesis via VEGF by activation of AKT-PIK3 pathway, and cell invasion by up-regulation of urokinase-type palsminogen activator. The emerging theme of pursuing the role of EMMPRIN as a functional biomarker in prostate cancer metastasis is being tested in the last year of the funding period. The results have also led us to determine the status of additional proteins that control the actin-cytoskeleton organization such as cofilin.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jul 01, 2012
Accession Number
ADA581392

Entities

People

  • Haining Zhu

Organizations

  • University of Kentucky

Tags

DTIC Thesaurus Topics

  • Cell Membrane
  • Cell Membrane Structures
  • Cell Movement
  • Cell Physiological Processes
  • Cells
  • Cellular Structures
  • Chemistry
  • Confocal Microscopy
  • Cytoskeleton
  • Intercellular Junctions
  • Medical Personnel
  • Oncology
  • Proteins
  • Proteomics

Fields of Study

  • Biology

Readers

  • Marine Propulsion Engineering and Naval Architecture
  • Oncology (Cancer Research).
  • Research Science/Academic Research

Technology Areas

  • Biotechnology